Hutchinson Capital Management Novartis Ag Transaction History

Hutchinson Capital Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$82.14 - $91.0 $441,831 - $489,489	-5,379 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $460,119 - $507,024	-5,379 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$64.91 - $73.36 $19,018 - $21,494	-293 Reduced 5.17%	5,379 $406,000
Q3 2017 Oct 30, 2017	BUY	$74.14 - $77.27 $420,522 - $438,275	5,672	5,672 $487,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Hutchinson Capital Management, based on Form 13F filings with the SEC.

Stay updated on Hutchinson Capital Management with notifications on news.